Transplantoux Health Evaluation Study (THES)

July 11, 2024 updated by: Universitaire Ziekenhuizen KU Leuven

Effect of an Exercise Training Intervention on Health-related Quality of Life and Psychosocial and Behavioral Variables in Adult Solid Organ Transplant Recipients: a Quasi-experimental Study Design

The primary aim is to evaluate the short- and long-term effect of the 'Transplantoux' exercise training intervention in solid organ transplant recipients with matched control sample of transplant recipients in view of selected Patient Reported Outcomes (PRO), i.e. health-related quality-of-life (HRQOL), psychosocial and behavioral variables, using a quasi-experimental design.

Study Overview

Detailed Description

During the last decades advances in solid organ transplantation, like e.g. organ preservation, surgical techniques and immunosuppressive treatment have contributed to improvements in postoperative survival. Thereby, solid organ transplantation (Tx) has moved from experimental treatment towards a clinical reality and a life-saving surgery, offering most patients a good long-term survival. However, further improvement in long-term survival remains a major challenge.

It is increasingly recognized that non-pharmacological interventions hold the potential to improve long-term outcomes in transplantation as evidence shows that health behavior has been independently associated with transplant outcome (e.g. physical activity, non-smoking, medication adherence). Furthermore, exercise training interventions show positive outcome in a number of populations and limited research in transplantation shows positive outcomes in view of exercise capacity, muscle strength, cardiopulmonary variables and body composition. However, there is a lack of research that evaluates exercise training interventions in view of patient reported outcomes (PROs) in transplant recipients.

In the University Hospitals of Leuven (Belgium) a project named 'Transplantoux' has been launched to enhance physical activity and exercise capacity in transplant recipients. Transplant recipients participate in the 'Transplantoux' exercise training intervention for 6-months with the ultimate goal to cycle or hike up the Mont Ventoux (France) (distance: 25.9 km, mean slope: 4.4%). Extending on a previous safety feasibility study in which we demonstrated that selected Transplant recipients can safely participate in an intense exercise program and that exercise capacity was significantly improved after training. The primary aim of the current study is to evaluate the short- and long-term effect of the 'Transplantoux' intervention in view of selected Patient Reported Outcomes (PROs), i.e. perceived health-related quality-of-life, depressive symptomatology, stress and well-being, physical activity, social contacts and social support, and barriers and motivators to exercise.

The Transplantoux Health Evaluation Study (THES) uses a quasi-experimental design with three convenience samples: 1) a convenience sample of solid organ transplant (Tx)-recipients participating in the Transplantoux exercise training intervention, 2) matched control sample of Tx-recipients not participating in the Transplantoux exercise intervention, and 3) and a convenience sample of healthy controls participating in the Transplantoux exercise intervention. Selected PROs will be assessed using validated self-reported questionnaire. Data collection will be performed at baseline, 3 months (in the middle of the training intervention), 6 months (immediately following the intervention), 9 months (3 months follow-up period) and 12 months (6 months follow-up period).

Study Type

Interventional

Enrollment (Estimated)

500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Ceulemans

Study Locations

      • Leuven, Belgium, 3000
        • Recruiting
        • University Hospitals Leuven
        • Sub-Investigator:
          • Laurens Ceulemans, MD
        • Sub-Investigator:
          • Sabina De Geest, RN, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

  1. Tx exercise group:

    Inclusion Criteria:

    • Tx recipient (heart, lung, liver, kidney, pancreas or small bowel)
    • Age between 18 - 70 years
    • More than 1y post-transplant

    Exclusion Criteria:

    • Rejection last 6 months
    • Severe co-morbidity
    • Contra-indication for severe exercise (e.g. cardiovascular disease)
    • Insufficient knowledge of Dutch language
  2. Tx matched control group

    Inclusion Criteria:

    • Tx recipient (heart, lung, liver, kidney, pancreas or small bowel)
    • Age between 18 - 70 years
    • More than 1y post-transplant

    Exclusion Criteria:

    • Rejection last 6 months
    • Insufficient knowledge of Dutch language
  3. Healthy exercise group:

Inclusion Criteria:

  • Age between 18 - 70 years

Exclusion Criteria:

  • Contra-indication for severe exercise
  • Insufficient knowledge of Dutch language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tx exercise group

Convenience sample of solid organ transplant recipients (heart, kidney, lung, liver, pancreas, small bowel) participating in the Transplantoux exercise training intervention.

Intervention:

  • Home-based individualized exercise training program
  • Supervised group training sessions
  • Climb of the Mont Ventoux
Based on these results of the cardiopulmonary exercise test (CPET) on a cycle ergometer, an individualized training program (cycling/hiking) is prescribed by a physical therapist for 6 months (3x/week, ≥30min/session).
7 supervised group training sessions (cycling/hiking) are organized by a physiotherapist
Cycle or hike up the Mont Ventoux (25.7 km, average slope 4.5%)
No Intervention: Tx matched control group
Controls are retrieved from the Leuven University Hospital heart, kidney, lung, liver, pancreas, small bowel transplant database and matched (1:4 matching) based on type of transplant, gender, age and time since transplant.
Experimental: Healthy exercise group

Convenience sample of health care providers (e.g. doctor, paramedic or medical companion involved in care programs for organ Tx) and patient's family members and friends participating in the Transplantoux exercise training intervention.

Intervention:

  • Supervised group training sessions
  • Climb of the mont ventoux
7 supervised group training sessions (cycling/hiking) are organized by a physiotherapist
Cycle or hike up the Mont Ventoux (25.7 km, average slope 4.5%)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in PROs (i.e. perceived quality of life, depressive symptomatology, stress and well-being, physical activity, and social contacts and support) in the Tx exercise group compared with Tx matched control group
Time Frame: baseline, 3, 6, 9 and 12 months
baseline, 3, 6, 9 and 12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in PROs (i.e. perceived quality of life, depressive symptomatology, stress and well-being, physical activity, and social contacts and support) in Tx exercise group compared with healthy exercise group
Time Frame: baseline, 3, 6, 9 and 12 months
baseline, 3, 6, 9 and 12 months
Compare PROs (i.e. perceived quality of life, depressive symptomatology, stress and well-being, physical activity, and social contacts and support) of the three groups with a representative sample of the Belgian population
Time Frame: baseline
baseline
Compare perceived barriers and motivators for physical exercise/activity in the three groups
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Diethard Monbaliu, MD, PhD, University Hospital Leuven, Abdominal Transplant Surgery

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Estimated)

January 1, 2025

Study Completion (Estimated)

January 1, 2025

Study Registration Dates

First Submitted

August 19, 2015

First Submitted That Met QC Criteria

August 21, 2015

First Posted (Estimated)

August 26, 2015

Study Record Updates

Last Update Posted (Actual)

July 12, 2024

Last Update Submitted That Met QC Criteria

July 11, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Home-based indiviualized exercise training program

Subscribe